News Wire ~ 3rd Party Press Release

197 POSTS 0 COMMENTS
Dupixent

FDA Approves Dupixent® as First Biologic for Treatment of Children Aged 6-11 with Moderate-to-Severe...

Three-quarters of patients receiving Dupixent achieved at least a 75% improvement in overall disease, with an average improvement of approximately 80%.
Research

New Insights on Allergies May Improve Diagnosis and Treatment

Findings may help to improve the diagnosis and treatment of allergies, pointing to a potential marker of these conditions and a new therapeutic strategy.
Allerject by Kaleo

Kaléo Announces ALLERJECT® Auto-Injector Will Be Available for Canadians at Risk for Anaphylaxis Starting...

ALLERJECT provides the allergy community with an alternative epinephrine auto-injector option with innovative features.
Celiac Disease Linked to Common Chemicals

Celiac Disease Linked to Common Chemical Pollutants

Research shows elevated blood levels of toxic chemicals found in pesticides, nonstick cookware, and fire retardants have been tied to an increased risk for celiac disease in young people.
Baby's First

FARE Launches Baby’s First: Reduce the Risk of Food Allergies

New Online Hub Dedicated to Raising Awareness and Educating New Parents on the Benefits of Early Introduction.

FARE Kicks Off Food Allergy Awareness Week 2020 with Activities and Webinars

Announces new content and programming dedicated to raising awareness of food allergy, Extends calendar of events before and beyond May 10-16, 2020
FARE Revised Algorithm

FARE Chief Medical Advisor Publishes New Guidance to Treat Patients Experiencing Anaphylaxis Amid COVID-19...

New recommendations come as patients suffering severe allergic reactions fear visiting emergency departments.

Milk Allergy Guidelines May Cause Overdiagnosis in Babies and Children

The team point to official guidelines for detecting cow’s milk allergy as a possible cause for the over-diagnosis.